{"name":"Mendus","slug":"mendus","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"DCP-001","genericName":"DCP-001","slug":"dcp-001","indication":"Type 2 diabetes","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"ilixadencel","genericName":"ilixadencel","slug":"ilixadencel","indication":"Other","status":"discontinued"}]}],"pipeline":[{"name":"DCP-001","genericName":"DCP-001","slug":"dcp-001","phase":"phase_2","mechanism":"DCP-001 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"ilixadencel","genericName":"ilixadencel","slug":"ilixadencel","phase":"discontinued","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQNDRzLXR5ZWhjV0VWTklKaWZydkhHaFBrNk1OeGx5Z2F1MEFvSXZiNDhNX3ZncHlkekNmaF8zSnI5Y2JJdWp1bnRIMFlKTDB2SmxGOEJ3ZzIzbGlGRGs4akYxVGlKUnJPeWxsQV93bF82bE9CWDJYZkQ4TnVBOWFoQmM0VERBQm1JOE5ZeUtoelVnRmpBMXc?oc=5","date":"2025-12-01","type":"pipeline","source":"The Pharma Letter","summary":"Mendus delivers on vididencel program milestone - The Pharma Letter","headline":"Mendus delivers on vididencel program milestone","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE1tekpNTXJwQ1pZVkZtZ0toZkt6SXh4bVRDT3J4aFUtZmlaNGU2SlExZjlwUmtGOUxac2FuNGdhRVlQVjFUbkJfbHljQm16SW1XS1RsS1BCbV9KdGhQRkRJdzY2c0tCdkxmTjNtMw?oc=5","date":"2024-06-03","type":"pipeline","source":"Biostock","summary":"News roundup Monday, June 3 - Biostock","headline":"News roundup Monday, June 3","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOb1JrZjNqNXpud2pzYU9FRF8zWVQzMXo1Vk9oSDJyX1ExQ0phM3BEVDF3SE1VS2FQZ3R3YTZnanNFWHA5RzRHcnY3T0dqYkVfRTI4UE9qVDZJSUlDNzNSd3lLOTV5YmNUZ0V1RzBjLVJaU1VNTVhkakZFQ053ck9vcEcyU3ZSNzh4YkxoSS1NSE9tOVFGVEY3Q0s4bXcybEFleVFLN1VraUd3MWYxa1E?oc=5","date":"2024-02-07","type":"pipeline","source":"Cision News","summary":"Bactiguard appoints Christine Lind as new CEO - Cision News","headline":"Bactiguard appoints Christine Lind as new CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPaVlOMEROYnRWbEhfZ3ZnYTRVZXF3WnpTWkZHU0NCcmNRZXZZV0xyVlBXb1ZydWFPVmdJb1R3cXhKWFpPdnVTcDVGWF9TdFZQUHVNc1FfZ01zX2NUMnBlM2FBY3Y3allhcDlOWk1yaTJmSzV6MFpFLWZUUEVJbUMxMEpFSlZEVzlmSVgzNmVB?oc=5","date":"2023-06-14","type":"pipeline","source":"Pharmaceutical Technology","summary":"Mendus and NorthX to establish cell therapy manufacturing unit - Pharmaceutical Technology","headline":"Mendus and NorthX to establish cell therapy manufacturing unit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPaWc2UFliTHVzcHgzR0lZV29PVTYzWjZmWjZwR2pGaVNZdlpkN00yYlVkOTEwUTRvaW9ObHNwS1diOFZfcGN3dk9wQmNWU3VkQ2xOckJKVm1BRFFqeTB1aFliZEstbXRaODRhaV91Ums1TjFjNWJKTGwyQ3ZhTWxBX1JWZzhyeWpWZ21ERkpSTXlkWlI2b2o5LTMyZzNqQ054NnNZQ2hoTzJiMVVaODdaOE55OXNHX2tUc3prNUdB?oc=5","date":"2023-06-12","type":"pipeline","source":"Contract Pharma","summary":"Mendus, NorthX Biologics Enter Strategic Cell Therapy Manufacturing Alliance - Contract Pharma","headline":"Mendus, NorthX Biologics Enter Strategic Cell Therapy Manufacturing Alliance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE0xdzBGSGN5NzlhOUpicnM4bTNQLTVVVE93RGQydHhPaGxjdGRsMW1Gemx0S0doeEhwYVlpbGc4MVNlTmFmQ3ZkeDhRTEc2QXBrVWR2eHhmb0taM241UkVDSnplbWloaHQybmd2V1RBUQ?oc=5","date":"2023-03-23","type":"pipeline","source":"Biostock","summary":"News roundup Thursday, March 23 - Biostock","headline":"News roundup Thursday, March 23","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTFBYZWp6OGh1UG91cWdEcV9QMTl2ODdXaFE1dEJwM3RUTjVvU3ZQNXhpWmt3VWxKR3RwWS1nb2hNQWZ3cG1LZFJFRm9UZHN1Q3FlUzFVUHgzcmgxU3NYWVhBNXczaFlKYjlZS2E2a1pKVQ?oc=5","date":"2022-10-12","type":"pipeline","source":"Biostock","summary":"The news sweep Wednesday 12 October - Biostock","headline":"The news sweep Wednesday 12 October","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"discontinued":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}